Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AVTX Avalo Therapeutics > Detailed Quotes

AVTX Avalo Therapeutics

Watchlist
3.490
-0.400-10.28%
Close  02/06 16:00 ET
High
3.910
Open
3.910
Turnover
338.90K
Low
3.070
Pre Close
3.890
Volume
100.32K
Market Cap
32.86M
P/E(TTM)
Loss
52wk High
11.280
Shares
9.41M
P/E(Static)
Loss
52wk Low
2.423
Float Cap
11.53M
Bid/Ask %
-17.24%
Historical High
91.799
Shs Float
3.30M
Volume Ratio
5.48
Historical Low
2.412
Dividend TTM
--
Div Yield TTM
--
P/B
-16.23
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.04%
Amplitude
21.59%
Avg Price
3.378
Lot Size
1
Float Cap
11.53M
Bid/Ask %
-17.24%
Historical High
91.799
Shs Float
3.30M
Volume Ratio
5.48
Historical Low
2.412
Dividend TTM
--
P/B
-16.23
Dividend LFY
--
Turnover Ratio
3.04%
Amplitude
21.59%
Avg Price
3.378
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Avalo Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
CEO: Dr. Garry A. Neil, M.D.
Market: NASDAQ
Listing Date: 11/13/2015
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist